Director-general of fair trading John Bridgeman has announced that he will ask the Restrictive Practices Court to overturn its 1970 decision allowing drug companies to fix the price of branded, over-the-counter pharmaceuticals. The decision has angered drug companies and pharmacy pressure groups who claim the abolition of re-sale price maintenance ...

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here